Prognostic impact of intrahepatic lymphatic and microvascular involvement in cases of colorectal liver metastases

International Journal of Colorectal Disease

Volumn 24, Issue 7, 2009, Pages 845-850

  Bockhorn, Maximilian ^a   Sotiropoulos, Georgios ^a   Neuhaus, Jan ^a   Sgourakis, George ^a   Sheu, Sien Yi ^b   Molmenti, Ernesto ^a   Fingas, Christian ^a   Trarbach, Tanja ^b   Frilling, Andreja ^a   Broelsch, Christoph E ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Liver metastases; Lymphatic vessel infiltration; Resection; Vascular invasion

Indexed keywords

FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

ADULT; ARTICLE; BILE LEAKAGE; CANCER ADJUVANT THERAPY; CANCER INFILTRATION; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ERYTHROCYTE TRANSFUSION; HUMAN; ILEUS; LENGTH OF STAY; LIVER FAILURE; LIVER METASTASIS; LIVER RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; MICROVASCULAR METASTASIS; ONCOLOGICAL PARAMETERS; OPERATION DURATION; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROGNOSIS; RESECTION MARGIN; SUBPHRENIC ABSCESS; SURGICAL MORTALITY; SURVIVAL RATE;

COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; HUMANS; LIVER NEOPLASMS; LYMPHATIC SYSTEM; MICROVESSELS; MIDDLE AGED; NEOADJUVANT THERAPY; PERIOPERATIVE CARE; PROGNOSIS; TREATMENT OUTCOME;

EID: 67349095367     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-009-0674-6     Document Type: Article

References (27)

1. Belli G, D'Agostino A, Ciciliano F et al (2002) Liver resection for hepatic metastases: 15 years of experience. J Hepatobiliary Pancreat Surg 9:607-613
2. Bodingbauer M, Tamandl D, Schmid K et al (2007) Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases. Br J Surg 94:1133-1138
3. DeMatteo RP, Fong Y, Blumgart LH (1999) Surgical treatment of malignant liver tumours. Baillieres Best Pract Res Clin Gastroenterol 13:557-574
4. Fusai G, Davidson BR (2003) Management of colorectal liver metastases. Colorectal Dis 5:2-23
5. van de Velde CJ (2005) Treatment of liver metastases of colorectal cancer. Ann Oncol 16(Suppl 2):iI144-ii119
6. Fong Y, Fortner J, Sun RL et al (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309-318
7. Scheele J, Altendorf-Hofmann A, Stangl R, Schmidt K (1996) Surgical resection of colorectal liver metastases: Gold standard for solitary and radically resectable lesions. Swiss Surg 4:4-17
8. Biasco G, Derenzini E, Grazi G et al (2006) Treatment of hepatic metastases from colorectal cancer: Many doubts, some certainties. Cancer Treat Rev 32:214-228
9. Choti MA, Sitzmann JV, Tiburi MF et al (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759-766
10. Minagawa M, Makuuchi M, Torzilli G et al (2000) Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: Long-term results. Ann Surg 231:487-499
11. Gayowski TJ, Iwatsuki S, Madariaga JR et al (1994) Experience in hepatic resection for metastatic colorectal cancer: Analysis of clinical and pathologic risk factors. Surgery 116:703-710
12. Liu LX, Zhang WH, Jiang HC (2003) Current treatment for liver metastases from colorectal cancer. World J Gastroenterol 9:193-200
13. Tanaka K, Shimada H, Matsuo K et al (2004) Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery 136:650-659
14. Pawlik TM, Scoggins CR, Zorzi D et al (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241:715-712
15. Sasaki A, Aramaki M, Kawano K et al (2002) Prognostic significance of intrahepatic lymphatic invasion in patients with hepatic resection due to metastases from colorectal carcinoma. Cancer 95:105-111
16. DeOliveira ML, Cunningham SC, Cameron JL et al (2007) Cholangiocarcinoma: Thirty-one-year experience with 564 patients at a single institution. Ann Surg 245:755-762
17. Nakajima T, Kondo Y, Miyazaki M, Okui K (1988) A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: Histologic classification and modes of spreading. Hum Pathol 19:1228-1234
18. Korita PV, Wakai T, Shirai Y et al (2007) Intrahepatic lymphatic invasion independently predicts poor survival and recurrences after hepatectomy in patients with colorectal carcinoma liver metastases. Ann Surg Oncol 14:3472-3480
19. Bockhorn M, Jain RK, Munn LL (2007) Active versus passive mechanisms in metastasis: Do cancer cells crawl into vessels, or are they pushed? Lancet Oncol 8:444-448
20. Nagashima I, Takada T, Matsuda K et al (2004) A new scoring system to classify patients with colorectal liver metastases: Proposal of criteria to select candidates for hepatic resection. J Hepatobiliary Pancreat Surg 11:79-83
21. Nordlinger B, Guiguet M, Vaillant JC et al (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77:1254-1262
22. Ueno H, Mochizuki H, Hashiguchi Y et al (2004) Predictors of extrahepatic recurrence after resection of colorectal liver metastases. Br J Surg 91:327-333
23. Parks R, Gonen M, Kemeny N et al (2007) Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: Analysis of data from two continents. J Am Coll Surg 204:753-761
24. Cady B, McDermott WV (1985) Major hepatic resection for metachronous metastases from colon cancer. Ann Surg 201:204-209
25. Liska V, Treska V, Holubec L et al (2007) Recurrence of colorectal liver metastases after surgical treatment: Multifactorial study. Hepatogastroenterology 54:1741-1744
26. Kohne CH, Folprecht G (2004) Current perspectives in the treatment of metastatic colorectal cancer. Ann Oncol Suppl 4:iV43-iv53
27. McCarthy M (2003) Antiangiogenesis drug promising for metastatic colorectal cancer. Lancet 361:1959